Congress has the sole constitutional authority to declare war. This resolution finds that no declaration of war or specific statutory authorization applies to ongoing hostilities and designates organizations and states involved after February 20, 2025.
It directs the President to terminate use of United States Armed Forces in hostilities against those entities unless Congress grants a declaration of war or a specific authorization for use of military force. The bill also preserves limited defense and counternarcotics authorities while reaffirming the importance of clear congressional authorization for major military engagements.
At a Glance
What It Does
Pursuant to 50 U.S.C. 1546a and related statutes, the resolution directs the President to terminate U.S. armed forces’ hostilities against entities designated after Feb 20, 2025 as FTOs or SDGTs, any states where those entities operate, and any non-state organizations involved in drug trafficking, unless a declaration of war or specific AUMF is enacted.
Who It Affects
The President, Department of Defense, and Combatant Commands are bound to withdraw or pause operations in these cases; defense contractors and allied partners coordinating with these operations are affected by post-withdrawal dynamics and planning.
Why It Matters
It reasserts Congress’s war powers, reduces ambiguity around authority to engage in hostilities, and sets a framework for withdrawal or reorientation of U.S. military posture absent new authorization.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill starts from a constitutional premise: Congress must authorize war. It catalogs several conditions under which hostilities have occurred without such authorization and notes recent actions that illustrate why a clear framework matters.
The resolution then directs the President to end U.S. military hostilities against any organization designated after February 20, 2025 as a foreign terrorist organization or specially designated global terrorist, any states where they operate, or any non-state organization involved in drug trafficking, unless Congress provides a declaration of war or a specific authorization for use of force. Although it imposes a withdrawal mandate, the bill preserves a narrow safety valve—defense of the United States from an armed attack and certain counternarcotics operations—so the executive branch can respond to imminent threats or civil authorities within those narrowly defined limits.
The findings section also clarifies that designation alone does not authorize force, and it references existing statutory procedures for expedited consideration of withdrawal actions.
The Five Things You Need to Know
The bill requires termination of hostilities against designated organizations and their states of operation unless Congress declares war or authorizes force.
Designation does not in itself authorize military action; a separate declaration of war or AUMF is still required.
The termination framework relies on established statutes (50 U.S.C. 1546a and the International Security Assistance and Arms Export Control Act of 1976).
The president can still defend the nation from armed attack or support civil authorities in counternarcotics operations, but only within defined limits.
Recent strikes cited in the bill illustrate why a clear authorization framework matters for future actions.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Findings and constitutional context
This section lays out the constitutional basis for congressional war powers, asserting that only Congress can declare war. It also catalogs findings about post-February 20, 2025 designations of foreign terrorist organizations (FTOs) and specially designated global terrorists (SDGTs), the lack of a declaration or specific AUMF for these actors, and the implications of recent strikes for the legal framework governing U.S. hostilities. The findings emphasize that designation alone does not grant presidential authority to use force and reference the War Powers framework and related authorities to frame the subsequent termination directive.
Termination of use of Armed Forces
This section directs the President to terminate the use of U.S. Armed Forces against any organization designated on or after February 20, 2025 as an FTO or SDGT, any states where those entities operate, or any non-state organization engaged in drug trafficking, unless a declaration of war or specific Authorization for Use of Military Force is enacted. It also provides a rule of construction allowing for defensive actions in response to an armed attack or imminent threat, and it preserves limited counternarcotics authority in those contexts. The termination obligation is anchored in the cited statutory framework (50 U.S.C. 1546a and related export-control provisions).
This bill is one of many.
Codify tracks hundreds of bills on Defense across all five countries.
Explore Defense in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Congressional oversight committees (House Foreign Affairs and Senate Foreign Relations) gain a clear statutory basis to assess and constrain executive military actions.
- The Department of Defense and Combatant Commands obtain a clearer, though restrictive, withdrawal framework—reducing ambiguity around when hostilities must end.
- U.S. service members and their families benefit from reduced exposure to engagements lacking explicit congressional authorization and a move toward clearer decision rules.
- U.S. taxpayers and the public benefit from greater transparency and accountability in military engagements connected to war powers.
- Allied governments and international partners gain clearer expectations about U.S. military commitments and the conditions under which force would be used.
Who Bears the Cost
- The President and DoD incur the requirement to terminate or reorient ongoing operations, potentially affecting force posture and readiness planning.
- Defense contractors supporting operations in the affected regions face program adjustments or contract realignments.
- Intelligence and diplomatic communities may need to adjust oversight and reporting to reflect the tighter authorization regime.
- Allies relying on ongoing U.S. deployments for deterrence might experience strategic disruption and reassessment of security arrangements.
- The public could face transitional costs if withdrawal creates short-term security gaps or requires rapid policy pivots.
Key Issues
The Core Tension
The central dilemma is balancing stringent congressional control over the use of force with the practical need to respond quickly to evolving threats. Requiring explicit authorization for any major engagement helps prevent open-ended or unauthorized actions, but it may also constrain a swift national security response in fast-moving situations.
The bill raises tensions between constitutional oversight and rapid national security responses. While it closes gaps created by actions taken without clear authorization, it also creates definitional and operational questions: what constitutes a qualifying designation post-February 20, 2025, how to measure imminent threat, and how to handle ongoing operations that began under different assumptions.
The absence of a mechanism for temporary waivers or emergency adjustments could lead to ad hoc withdrawals or strategic uncertainty. The framework depends on precise interpretation of terms like “organization designated after” a date, the scope of “states in which those entities operate,” and what qualifies as a non-state organization engaged in drug trafficking, all of which could become contested in practice.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.